E-LIB Suche - Ergebnisse für: Einolf, Heidi J.

1

MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythm..:

Uddin, Muhammad Erfan ; Eisenmann, Eric D. ; Li, Yang...
International Journal of Molecular Sciences. 23 (2022) 15 - p. 8607 , 2022

Link: https://doi.org/10.3390/..

2

Model‐Informed Drug Development for Everolimus Dosing Selec..:

Combes, Francois Pierre ; Einolf, Heidi J. ; Coello, Neva...
CPT: Pharmacometrics & Systems Pharmacology. 9 (2020) 4 - p. 230-237 , 2020

Link: https://doi.org/10.1002/..

3

Practical Assessment of Clinical Drug–Drug Interactions in ..:

Shebley, Mohamad ; Einolf, Heidi J.
Clinical Pharmacology & Therapeutics. 105 (2019) 6 - p. 1326-1328 , 2019

Link: https://doi.org/10.1002/..

4

Evaluation of the time-course of CYP Induction and impact o..:

Hariparsad, Niresh ; Einolf, Heidi ; Buckley, David...
Drug Metabolism and Pharmacokinetics. 34 (2019) 1 - p. S40 , 2019

Link: https://doi.org/10.1016/..

5

Recommendations for the Design of Clinical Drug–Drug Intera..:

Chen, Yuan ; Cabalu, Tamara D. ; Callegari, Ernesto...
CPT: Pharmacometrics & Systems Pharmacology. 8 (2019) 9 - p. 685-695 , 2019

Link: https://doi.org/10.1002/..

6

Recommendations for in vitro CYP3A4 mRNA data analysis for ..:

Tweedie, Donald ; Kenny, Jane R. ; Ramsden, Diane...
Drug Metabolism and Pharmacokinetics. 34 (2019) 1 - p. S44 , 2019

Link: https://doi.org/10.1016/..

7

Considerations from the IQ induction working group in respo..:

Hariparsad, Niresh ; Einolf, Heidi ; Kenny, Jane...
Drug Metabolism and Pharmacokinetics. 33 (2018) 1 - p. S52 , 2018

Link: https://doi.org/10.1016/..

8

Physiologically Based Pharmacokinetic Model Qualification a..:

Shebley, Mohamad ; Sandhu, Punam ; Emami Riedmaier, Arian...
Clinical Pharmacology & Therapeutics. 104 (2018) 1 - p. 88-110 , 2018

Link: https://doi.org/10.1002/..

9

Evaluation of Drug-Drug Interaction Potential Between Sacub..:

Lin, Wen ; Ji, Tao ; Einolf, Heidi...
Journal of Pharmaceutical Sciences. 106 (2017) 5 - p. 1439-1451 , 2017

Link: https://doi.org/10.1016/..

10

Drug Interaction Potential of Osilodrostat (LCI699) Based o..:

Armani, Sara ; Ting, Lillian ; Sauter, Nicholas...
Clinical Drug Investigation. 37 (2017) 5 - p. 465-472 , 2017

Link: https://doi.org/10.1007/..

11

Clinical disposition, metabolism and in vitro drug–drug int..:

Flarakos, Jimmy ; Du, Yancy ; Gu, Helen...
Xenobiotica. 47 (2016) 8 - p. 682-696 , 2016

Link: https://doi.org/10.1080/..

12

Physiologically based pharmacokinetic modeling for assessin..:

Xia, Binfeng ; Barve, Avantika ; Heimbach, Tycho...
European Journal of Pharmaceutical Sciences. 63 (2014) - p. 103-112 , 2014

Link: https://doi.org/10.1016/..

13

Time‐Dependent Inhibition and Induction of Human Cytochrome..:

Dhuria, Shyeilla ; Einolf, Heidi ; Mangold, James...
The Journal of Clinical Pharmacology. 53 (2013) 6 - p. 642-653 , 2013

Link: https://doi.org/10.1002/..

14

The Conduct of In Vitro and In Vivo Drug‐Drug Interaction S..:

Bjornsson, Thorir D. ; Callaghan, John T. ; Einolf, Heidi J....
The Journal of Clinical Pharmacology. 43 (2003) 5 - p. 443-469 , 2003

Link: https://doi.org/10.1177/..

15

The Conduct of In Vitro and In Vivo Drug-Drug Interaction S..:

Bjornsson, Thorir D. ; Callaghan, John T. ; Einolf, Heidi J....
Journal of Clinical Pharmacology. 43 (2003) 5 - p. 443-469 , 2003

Link: https://doi.org/10.1177/..